Prognostic Value of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) Expression in Resected Non-small Cell Lung Cancer
![]() ![]() |
Kim, Seung Joon
(Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Lee, Jung Mi (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Jin Sook (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kang, Ji Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Lee, Sang Hak (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Seok Chan (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Lee, Sook Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Chi Hong (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Ahn, Joong Hyun (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kwon, Soon Seog (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Young Kyoon (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Kwan Hyoung (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Moon, Hwa Sik (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Song, Jeong Sup (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Park, Sung Hak (Department of Internal Medicine, The Catholic University of Korea College of Medicine) Moon, Seok Hwan (Department of Thoracic and Cardiovascular Surgery, The Catholic University of Korea College of Medicine) Wang, Yeong Pil (Department of Thoracic and Cardiovascular Surgery, The Catholic University of Korea College of Medicine) |
1 | Ravdin PM, Davis G. Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Lung Cancer 2006;52:207-12 DOI ScienceOn |
2 | Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9 DOI |
3 | Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 1992;3:81-7 |
4 | Ko HJ, Park JH, Shim H, Yang SH, Jeong ET. Prognostic value of vascular endothelial growth factor (VEGF) in resected non-small cell lung cancer. Tuberc Respir Dis 2001;50:676-85 DOI |
5 | Choi Y, Kim Y, Hong YC, Park SK, Yoo KY. Temporal changes of lung cancer mortality in Korea. J Korean Med Sci 2007;22:524-8 DOI ScienceOn |
6 | Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6 DOI ScienceOn |
7 | Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006;51:143-58 DOI ScienceOn |
8 | Onn A, Herbst RS. Angiogenesis and lung cancer: implications for prognosis and treatment. Lancet Oncol 2007;8:460-1 DOI ScienceOn |
9 | Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 2004;25:443-8 DOI ScienceOn |
10 | Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69 Suppl 3:4-10 DOI ScienceOn |
11 | Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch 2001;439:645-52 DOI |
12 | Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 anti-body and anti-CD105 antibody. Clin Cancer Res 2001;7:3410-5 |
13 | Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005;94:209-31 |
14 | Cebe-Suarez S, Zehnder-Fjallman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis: complex partnerships. Cell Mol Life Sci 2006;63:601-15 DOI |
15 | Kiselyov A, Balakin KV, Tkachenko SE. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin Investig Drugs 2007;16:83-107 DOI ScienceOn |
16 | Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002;282:C947-70 DOI |
17 | Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22:201-7 DOI ScienceOn |
18 | Anderson IC, Mari SE, Broderick RJ, Mari BP, Shipp MA. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures. Cancer Res 2000;60:269-72 |
19 | Rong Y, Durden DL, Van Meir EG, Brat DJ. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006;65:529-39 DOI |
20 | Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999;185:45-106 |
21 | Lee SN. The prognostic role of vascular endothelial growth factor (VEGF) expression and angiogenesis in curatively resected non-small cell lung cancer. J Korean Cancer Assoc 1999;31:1210-8 |
![]() |